These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 7717793)
1. Prolonged use of methotrexate for sarcoidosis. Lower EE; Baughman RP Arch Intern Med; 1995 Apr; 155(8):846-51. PubMed ID: 7717793 [TBL] [Abstract][Full Text] [Related]
2. [Value of methotrexate in a case of florid cutaneous sarcoidosis]. Morin G; De Wazières B; Humbert P; Dupond JL Ann Dermatol Venereol; 1993; 120(2):143-6. PubMed ID: 8363307 [TBL] [Abstract][Full Text] [Related]
6. Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: a comparative study. Ross HJ; Gullestad L; Pak J; Slauson S; Valantine HA; Hunt SA J Heart Lung Transplant; 1997 Feb; 16(2):179-89. PubMed ID: 9059929 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of tacrolimus in rheumatoid arthritis patients who have been treated unsuccessfully with methotrexate: a six-month, double-blind, randomized, dose-ranging study. Furst DE; Saag K; Fleischmann MR; Sherrer Y; Block JA; Schnitzer T; Rutstein J; Baldassare A; Kaine J; Calabrese L; Dietz F; Sack M; Senter RG; Wiesenhutter C; Schiff M; Stein CM; Satoi Y; Matsumoto A; Caldwell J; Harris RE; Moreland LW; Hurd E; Yocum D; Stamler DA Arthritis Rheum; 2002 Aug; 46(8):2020-8. PubMed ID: 12209503 [TBL] [Abstract][Full Text] [Related]
9. Low dose methotrexate therapy is effective in late-onset atopic dermatitis and idiopathic eczema. Zoller L; Ramon M; Bergman R Isr Med Assoc J; 2008 Jun; 10(6):413-4. PubMed ID: 18669134 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of methotrexate in recalcitrant cutaneous lupus erythematosus: results of a retrospective study in 43 patients. Wenzel J; Brähler S; Bauer R; Bieber T; Tüting T Br J Dermatol; 2005 Jul; 153(1):157-62. PubMed ID: 16029342 [TBL] [Abstract][Full Text] [Related]
11. Muscle involvement in sarcoidosis: a retrospective and followup studies. Fayad F; Lioté F; Berenbaum F; Orcel P; Bardin T J Rheumatol; 2006 Jan; 33(1):98-103. PubMed ID: 16395757 [TBL] [Abstract][Full Text] [Related]
13. An open-label, noncomparative study of miglustat in type I Gaucher disease: efficacy and tolerability over 24 months of treatment. Pastores GM; Barnett NL; Kolodny EH Clin Ther; 2005 Aug; 27(8):1215-27. PubMed ID: 16199246 [TBL] [Abstract][Full Text] [Related]
14. [The effect of therapeutic intervention with corticosteroids on outcome and prognosis of sarcoidosis]. Miao JZ; Du DJ; Zeng P Zhonghua Jie He He Hu Xi Za Zhi; 2003 Jan; 26(1):14-7. PubMed ID: 12775262 [TBL] [Abstract][Full Text] [Related]
15. Presentations and outcomes of neurosarcoidosis: a study of 54 cases. Pawate S; Moses H; Sriram S QJM; 2009 Jul; 102(7):449-60. PubMed ID: 19383611 [TBL] [Abstract][Full Text] [Related]